The European Medicines Agency (EMA) has approved the Covid-19 vaccine developed by US biotech company Moderna for use across the EU, making it the second jab given the green light across the 27-nation bloc so far in the pandemic.
The EU drug regulator recommended granting the vaccine a conditional marketing authorization for use in people aged 18 and over, according to a statement released by the agency on Tuesday.
Emer Cooke, Executive Director of the EMA described the vaccine as “another tool to overcome the current emergency,” adding that the regulator’s work would “always be guided by the scientific evidence.”